US2021009655A1PendingUtilityA1
Methods and compositions for generating an immune response by inducing cd40 and pattern recognition receptor adapters
Est. expirySep 22, 2028(~2.2 yrs left)· nominal 20-yr term from priority
A61K 40/42A61K 40/30A61K 40/24A61K 40/19A61K 40/11A61K 40/10A61K 40/00A61K 2239/38A61K 2239/31C12N 5/0639C12N 9/90C12N 2710/10343A61P 31/00C12N 7/00C12Y 502/01008C12N 2510/00C12N 2501/998C07K 14/4705C12N 15/86C12N 2501/70C07K 2319/033C07K 14/70578A61P 43/00A61P 37/04A61P 31/04A61P 35/00C07K 14/4702C12N 2501/52A61K 2039/5154
72
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Provided are methods for activating an antigen-presenting cell and eliciting an immune response by inducing an inducible pattern recognition receptor adapter, or adapter fragment, and CD40 activity. Also provided are nucleic acid compositions comprising sequences coding for chimeric proteins that include an inducible CD40 peptide and an inducible pattern recognition receptor adapter or adapter fragment.
Claims
exact text as granted — not AI-modified1 - 16 . (canceled)
17 . An isolated nucleic acid comprising a promoter operatively linked to a polynucleotide, in order from 5′ to 3′, encoding a chimeric protein, wherein the chimeric protein comprises:
(a) a truncated MyD88 polypeptide lacking the TIR domain, wherein the truncated MyD88 polypeptide comprises amino acid residues 1-172 and does not include contiguous amino acid residues 173-296 of a full length native human MyD88 polypeptide,
(b) a CD40 cytoplasmic polypeptide region lacking the CD40 extracellular domain; and
(c) at least two FKBP12 multimeric ligand-binding regions.
18 . The isolated nucleic acid of claim 17 , wherein each of said at least two FKBP12 multimeric ligand-binding regions bind to AP1903 or AP20187.
19 . The isolated nucleic acid of claim 17 , wherein each of said at least two FKBP12 multimeric ligand-binding regions comprise an amino acid substitution at position 36.
20 . The isolated nucleic acid of claim 17 , wherein each of said at least two FKBP12 multimeric ligand-binding region comprises a FKBP12(V36) polypeptide.
21 . The isolated nucleic acid of claim 17 , wherein the nucleic acid is contained within an isolated vector.
22 . The nucleic acid of claim 21 , wherein the nucleic acid is contained within an isolated viral vector.
23 . The nucleic acid of claim 21 , wherein the nucleic acid is contained within an isolated plasmid vector.
24 . An isolated cell transduced or transfected with a vector of claim 21 .
25 . A method for activating a cell, comprising transfecting or transducing the cell with a vector of claim 21 , and contacting the transfected or transduced cell with a ligand that binds to the ligand binding region, whereby the cell is activated.
26 . The method of claim 25 , wherein the ligand is AP1903 or AP20187.Join the waitlist — get patent alerts
Track US2021009655A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.